Brief: Lombard Medical and MicroPort Scientific Corporation announce strategic partnership and investment agreement

Lombard Medical

19/12/2016 11:00

Dec 19 (Reuters) - Lombard Medical Inc  EVAR.O  
    * Lombard Medical and MicroPort Scientific Corporation 
announce strategic partnership and investment agreement 
    * Lombard Medical says agreement provides MicroPort 
exclusive marketing rights for Lombard Medical's Aorfix, Altura 
AAA stent graft product lines in China 
    * Agreement provides microport right to a technology license 
to manufacture products for China market 
    * MicroPort has invested $15 million in a combination of 
Lombard Medical common stock and convertible debt 
    * Lombard Medical Inc says Lombard Medical will also appoint 
two representatives of MicroPort to serve on its board of five 
non-executive directors 
    * MicroPort will also have exclusive marketing rights for 
both Altura and Aorfix in Brazil 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBwR6PFja 
Further company coverage:  EVAR.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))